Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 6.65 is in line with its 5-year average of 7.25, around the middle of its 5-year range (4.90–9.72).
As of the fiscal period ended Tuesday, June 30, 2026. 13.72% above its 12-month average of 5.85.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.65.
QUICK RATIO (ACID-TEST)
6.65
QUICK RATIO (ACID-TEST) AVG TTM
5.85
QUICK RATIO (ACID-TEST) AVG 3Y
6.97
QUICK RATIO (ACID-TEST) AVG 5Y
7.25
QUICK RATIO (ACID-TEST) AVG 10Y
8.34
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+13.72%
CURRENT VS 3Y AVG
-4.66%
CURRENT VS 5Y AVG
-8.27%
CURRENT VS 10Y AVG
-20.24%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.28
median of 97 covered companies
CURRENT VS SECTOR MEDIAN
+419.41%
vs the sector median at left
Intellia Therapeutics, Inc.
Market Cap
$1.72B
Quick Ratio (Acid-Test)
6.65
TTM Avg
5.85
3Y Avg
6.97
5Y Avg
7.25
Market Cap
$1.73B
Quick Ratio (Acid-Test)
1.07
TTM Avg
0.89
3Y Avg
0.95
5Y Avg
0.97
Market Cap
$2.14B
Quick Ratio (Acid-Test)
5.03
TTM Avg
4.66
3Y Avg
4.92
5Y Avg
7.11
Market Cap
$1.00B
Quick Ratio (Acid-Test)
0.81
TTM Avg
2.16
3Y Avg
2.71
5Y Avg
2.89
Market Cap
$2.51B
Quick Ratio (Acid-Test)
14.57
TTM Avg
8.96
3Y Avg
7.17
5Y Avg
6.28
Market Cap
$2.74B
Quick Ratio (Acid-Test)
6.07
TTM Avg
7.05
3Y Avg
8.10
5Y Avg
8.04
Market Cap
$472.39M
Quick Ratio (Acid-Test)
3.35
TTM Avg
2.92
3Y Avg
4.56
5Y Avg
5.25
Market Cap
$397.55M
Quick Ratio (Acid-Test)
8.92
TTM Avg
6.16
3Y Avg
7.06
5Y Avg
7.06
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intellia Therapeutics, Inc. (NTLA) | $1.72B | 6.65 | 5.85 | 6.97 | 7.25 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | 1.07 | 0.89 | 0.95 | 0.97 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.14B | 5.03 | 4.66 | 4.92 | 7.11 |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | 0.81 | 2.16 | 2.71 | 2.89 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.51B | 14.57 | 8.96 | 7.17 | 6.28 |
| TransMedics Group, Inc. (TMDX)vs › | $2.74B | 6.07 | 7.05 | 8.10 | 8.04 |
| NeoGenomics, Inc. (NEO)vs › | $472.39M | 3.35 | 2.92 | 4.56 | 5.25 |
| NRC Health (NRC)vs › | $459.30M | 0.65 | 0.55 | 0.77 | 1.10 |
| Shoulder Innovations, Inc. (SI)vs › | $397.55M | 8.92 | 6.16 | 7.06 | 7.06 |
| PDS Biotechnology Corporation (PDSB)vs › | $41.03M | 0.57 | 2.81 | 4.44 | 7.47 |
Quick Ratio
6.65
Excludes inventory
Current Ratio
6.65
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 6.65 |
| 2026-03-31 | 6.10 |
| 2025-12-31 | 5.08 |
| 2025-09-30 | 6.21 |
| 2025-06-30 | 5.19 |
| 2025-03-31 | 4.90 |
| 2024-12-31 | 5.77 |
| 2024-09-30 | 6.73 |
| 2024-06-30 | 7.21 |
| 2024-03-31 | 9.03 |
| 2023-12-31 | 8.67 |
| 2023-09-30 | 9.72 |
| 2023-06-30 | 9.41 |
| 2023-03-31 | 9.32 |
| 2022-12-31 | 9.61 |
| 2022-09-30 | 6.55 |
| 2022-06-30 | 7.24 |
| 2022-03-31 | 6.94 |
| 2021-12-31 | 6.11 |
| 2021-09-30 | 8.35 |
| 2021-06-30 | 7.43 |
| 2021-03-31 | 9.90 |
| 2020-12-31 | 9.59 |
| 2020-09-30 | 7.45 |
| 2020-06-30 | 7.55 |
| 2020-03-31 | 7.64 |
| 2019-12-31 | 8.12 |
| 2019-09-30 | 7.89 |
| 2019-06-30 | 7.86 |
| 2019-03-31 | 7.74 |
| 2018-12-31 | 8.01 |
| 2018-09-30 | 11.53 |
| 2018-06-30 | 12.62 |
| 2018-03-31 | 13.20 |
| 2017-12-31 | 11.32 |
| 2017-09-30 | 8.88 |
| 2017-06-30 | 9.33 |
| 2017-03-31 | 10.48 |
| 2016-12-31 | 9.15 |
| 2016-09-30 | 12.93 |
| 2016-06-30 | 14.01 |
| 2016-03-31 | 6.02 |
| 2015-12-31 | 7.26 |
| 2015-09-30 | 8.11 |
| 2015-06-30 | 2.06 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 4.30 |
| 2014-06-30 | 0.00 |
